Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

shutterstock_292920209

Alternative treatment cures rare blood disease for first time

March 22, 2017 Research and Development congenital dyserythropoietic anaemia

A Chicago man has become the first person ever documented to be cured of congenital dyserythropoietic anaemia (CDA), a rare …
News
gsk_boronia_australia

GSK begins £92 million expansion of UK site

March 22, 2017 Manufacturing and Production, Research and Development GSK, UK

GSK has officially broken ground on the expansion of its site in County Durham. The expanded site will be an …
News
heartbeat

Novartis heart failure drug sinks at Phase 3 trials

March 22, 2017 Research and Development Acute heart failure, Novartis, serelaxin

Novartis’ serelaxin was once thought to be the major hope for its cardiovascular pipeline – analysts projected it to become …
News

Novartis’ psoriasis drug allows some patients to go into remission

March 21, 2017 Research and Development Cosentyx, Novartis, psoriasis

Novartis released data on patient’s reaction to Cosentyx for the treatment of psoriasis, finding that as many as 21% of …
News
shutterstock_291014192

Asia-Pacific NSCLC market to more than double to $6.2bn by 2023

March 21, 2017 Manufacturing and Production, Research and Development, Sales and Marketing BMS, Eli Lilly, MSD, NSCLC, Yervoy, keytruda, opdivo

New research from intelligence provider GBI Research has indicated that the non-small cell lung cancer (NSCLC) market in the Asia-Pacific …
News
lilly_scientists

Lilly’s breast cancer drug meets primary endpoint

March 21, 2017 Manufacturing and Production, Research and Development CDK 4/6 inhibitors, Eli Lilly, abemaciclib

Eli Lilly has announced that its trial of abemaciclib, in combination with fulvestrant, had met its primary endpoint of progression-free …
News

India aims to become “a global innovation hub” for biotechs by 2020

March 21, 2017 Manufacturing and Production, Research and Development India, biotech

The Indian Government has announced its intention to transform the nation into a hub for global biotech activity via its …
News
shutterstock_311949818

Genentech plans second Phase 3 Alzheimer’s trial following endpoint failures

March 20, 2017 Research and Development, Sales and Marketing Alzheimer's, Genentech, Roche

Genentech, Roche’s biotech group, has announced its plans to conduct a second Phase 3 study for crenezumab, its anti-Abeta antibody …
News
pulmocide-logo

UK biotech Pulmocide secures $30m for inhalable lung disease therapies

March 20, 2017 Research and Development, Sales and Marketing pulmocide, pulmonary aspergillosis, respiratory syncytial virus

Pulmocide, a UK biotech run by a former GlaxoSmithKline scientists and based in London, has secured $30.4 million in Series …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

March 17, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

As another week comes and goes, waves were sent through the industry as Trump announced his pick as the new …
News
anirvan_ghosh

Biogen swoops to appoint Ex-Roche Vice President

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen

Biogen have appointed Anirvan Ghosh to the position of Senior Vice President of research and Early Development. Ghosh is slated …
Appointment
7808465302_a335c6dd4f_o

The rising threat of antibiotic resistance

March 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing antibiotic resistance

Last month, researchers from the University of California, Los Angeles (UCLA) revealed findings that showed that utilising antibiotics in combination …
Feature
heartbeat

Decade lifespan difference in Americans and Canadians with cystic fibrosis

March 15, 2017 Research and Development Canada, United States, cystic fibrosis

A new study has emerged looking into life expectancy of those with cystic fibrosis, funded by the US Cystic Fibrosis …
News
opdivo_1_1

NICE recommends against Opdivo for classical Hodgkin lymphoma

March 15, 2017 Research and Development, Sales and Marketing BMS, classical Hodgkin Lymphoma, opdivo

The National Institute of Health and Care Excellence (NICE) has released draft guidance provisionally turning down Bristol-Myers Squibb’s Opdivo (nivolumab) …
News
shutterstock_156022646

FDA-approved preterm birth drug has no benefit and may cause harm, study suggests

March 15, 2017 Research and Development FDA, Makena

A study by the UT Southwestern Medical Center has found that the synthetic progestogen hormone 17-alpha hydroxyprogesterone caproate (17-OHPC), a …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026